The Tumor Imaging Metrics Core (TIMC) is a collaborative effort among Mass General, Brigham and Women's Hospital and the Dana-Farber Cancer Institute.



As an independant lab, the Tumor Imaging Metrics Core provides objective anatomic and functional imaging measurements to enhance the efficiency and quality of image-based clinical trials.

Our mission is to:

  • provide reliable and consistent standardized radiological measurements to evaluate treatment response for oncology clinical trials
  • promote research and educational efforts in relation to assessment criteria